 | |
| Discipline | Pharmacovigilance |
|---|---|
| Language | English |
| Edited by | Roger McIntyre |
| Publication details | |
| History | 2002-present |
| Publisher | Informa |
| Frequency | Monthly |
| Impact factor | 4.011 (2021) |
| Standard abbreviations ISO 4 (alt) · Bluebook (alt) NLM (alt) · MathSciNet (alt  ) | |
| ISO 4 | Expert Opin. Drug Saf. |
| Indexing CODEN (alt · alt2) · JSTOR (alt) · LCCN (alt) MIAR · NLM (alt) · Scopus | |
| CODEN | EODSA9 |
| ISSN | 1474-0338 (print) 1744-764X (web) |
| OCLC no. | 858598983 |
| Links | |
Expert Opinion on Drug Safety is an international peer-reviewed medical journal publishing review articles on all aspects of pharmacovigilance and original papers on the clinical implications of drug treatment safety issues. It was established in 2002 and is published by Informa. The editor-in-chief is Roger McIntyre (University of Toronto).
Abstracting and indexing
The journal is abstracted and indexed in Chemical Abstracts, EMBASE/Excerpta Medica, Index Medicus/MEDLINE, and the Science Citation Index Expanded. According to the Journal Citation Reports, the journal has a 2021 impact factor of 4.011.
References
- "Expert Opinion on Drug Safety". 2021 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2018.
{{cite book}}: CS1 maint: postscript (link)
External links
  | This article about a pharmacology journal is a stub. You can help Misplaced Pages by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |